Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
USNA — USANA Health Sciences, Inc.
NYSE
FULL STOCK PAGE →

Q2 2026 Earnings Call Summary

AUG 5, 2026
REVENUE
$223.3M -10.8%
NET MARGIN
-9.6% -12.6 PTS
EPS
-$1.16 -382.9%
FREE CASH FLOW
$20.2M +183.4%

No summary has been written for this call yet.